Tevogen Bio Holdings Inc. — Form 8-K
Filed July 30, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Tevogen Bio Holdings Inc. amended its certificate of incorporation on July 30, 2026, changing its legal name to 'Tevogen Inc.' The amendment was unanimously approved by the Board of Directors under Delaware General Corporation Law Section 242, without stockholder vote. Concurrent with the name change, the company adopted amended and restated bylaws, effective the same date, which are standard corporate governance provisions covering stockholder meetings, director elections, committees, officer roles, indemnification, and stock matters.
Why this rating
Name change alone is administrative/branding; no operational, financial, or strategic business impact. Standard corporate governance housekeeping.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.